[HTML][HTML] Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific reports, 2022 - nature.com
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

[PDF][PDF] Immunogenicity of ChAdOx1 nCoV‑19 vaccine after a two‑dose inactivated SARS‑CoV‑2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific …, 2022 - scienceopen.com
Materials and methods Study design. A single-arm clinical trial (CVIM2/ICON2 study) was
performed between July 2021 and September 2021 at Ramathibodi Hospital, Mahidol …

[HTML][HTML] Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific …, 2022 - ncbi.nlm.nih.gov
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific Reports, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Vaccination with inactivated SARS-CoV-2 virus
produces suboptimal immune responses among kidney transplant (KT), peritoneal dialyzed …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom… - Scientific …, 2022 - mahidol.elsevierpure.com
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific …, 2022 - ui.adsabs.harvard.edu
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.

J Bruminhent, C Setthaudom, R Kitpermkiat… - 2022 - cabidigitallibrary.org
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific …, 2022 - search.ebscohost.com
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.

J Bruminhent, C Setthaudom, R Kitpermkiat… - Scientific …, 2022 - europepmc.org
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients

J Bruminhent, C Setthaudom… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients …